Fusion Antibodies makes £1.1m loss as it restructures business

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 77%

Business News News

Business Business Latest News,Business Business Headlines

Belfast biotech firm says it is re-positioning company’s service offering to best serve clients via IrishTimesBiz

Mon Dec 5 2022 - 08:14

Fusion Antibodies, the Belfast-based contract research firm, made a loss of £1.1 million for the six months to the end of September as it attempts to restructure the business. The company’s latest half-year results show group revenue also fell to £1.9 million, down from £2.4 million for the same period last year, while spending on research and development rose by 7 per cent to £450,000.“We are re-positioning the company’s service offering to best serve our clients in therapeutic antibody drug discovery.”

“Following the restructuring of our commercial team and once again attending in-person conferences this is the right time to re-align our services with client needs,” he said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines